Showing 451-460 of 779 results for "".
Biosimilar Medicines in Dermatology: Key Aspects
https://practicaldermatology.com/topics/psoriasis/biosimilar-medicines-in-dermatology-key-aspects/22929/After the recent enactment of a specific approval pathway for biosimilars and publication of the first draft guidelines on biosimilar product development by the FDA, biosimilars are expected to be available in the US soon.Update on Isotretinoin, Depression, and Suicide: Appropriate Monitoring is Key
https://practicaldermatology.com/topics/general-topics/update-on-isotretinoin-depression-and-suicide-appropriate-monitoring-is-key/21859/Data have failed to show a direct relationship between isotretinoin use and depression or suicide, but the cumulative evidence suggests patients with severe acne require careful monitoring.Medical Dermatology Myths
https://practicaldermatology.com/topics/general-topics/medical-dermatology-myths/22036/Here are the facts about seven common misconceptions that may hinder effective patient care.Prescriber, Beware: Understanding and Protecting Drug Compounding
https://practicaldermatology.com/topics/practice-management/prescriber-beware-understanding-and-protecting-drug-compounding/20582/Compounding has been an integral part of the specialty, but changing regulations and new players may converge to bring change.Optimizing Acne Treatment: The Importance of the First Follow-up
https://practicaldermatology.com/topics/general-topics/optimizing-acne-treatment-the-importance-of-the-first-follow-up/20972/The first follow-up visit is a time to measure efficacy and compliance, reinforce key messages, make adjustments to the regimen, and discuss acne sequela.Prescribing Pitfalls, Part I: Navigate the Changing Landscape of Brand Name Drug Prescribing
https://practicaldermatology.com/topics/practice-management/prescribing-pitfalls-part-i-navigate-the-changing-landscape-of-brand-name-drug-prescribing/21440/Prescribers increasingly need to understand drug pricing, pharmacy policies, insurance coverage, and coupon offers to ensure patients get the medications they need.Why Are Dermatologists Not Writing Biologics?
https://practicaldermatology.com/topics/practice-management/why-are-dermatologists-inoti-writing-biologics/23427/Biologics have been shown to be both safe and effective for a variety of indications, so why don’t more dermatologists prescribe them?Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-2/23000/Antioxidants and Skin Cancer Risk: A Look at Vitamins A and B
https://practicaldermatology.com/topics/skin-cancer-photoprotection/antioxidants-and-skin-cancer-risk-a-look-at-vitamins-a-and-b/23106/There is some evidence to suggest that higher intake of these antioxidants may reduce skin cancer risks.Angioleiomyoma in a Rare Location
https://practicaldermatology.com/topics/other-dermatology/angioleiomyoma-in-a-rare-location/24012/A minimally invasive treatment is used to treat a tumor in a cosmetically sensitive area.